Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.

British journal of cancer - 6 Nov 2012

Joshi H, Bhanot G, Børresen-Dale A-L, Kristensen V

Abstract excerpt

BACKGROUND: Targeting differentially activated or perturbed tumour pathways is the key idea in individualised cancer therapy, which is emerging as an important option in treating cancers with poor prognostic profiles. TP53 mutation status is known as a core determinant of survival in breast cancer. The pathways disrupted in association with TP53 mutation status in tumours are not well characterised. METHOD: In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cell Transformation, Neoplastic
Share to Receptors, Estrogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA, Messenger

Share to Transcriptome

Share to Tumor Suppressor Protein p53

Share to Up-Regulation

Share to Vascular Endothelial Growth Factor A

Source

Open in PubMed Open full text

Identifiers

PMID: 23079576
DOI: 10.1038/bjc.2012.461
PMCID: PMC3493873

Genes

VEGFA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.PMID 23079576Read ↗

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.Semantic proximity Read ↗

VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy.Semantic proximity Read ↗

TP53Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast CancerSemantic proximity Read ↗

TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics.Semantic proximity Read ↗

The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.Semantic proximity Read ↗

Capturing the Variations in Mutant p53-Driven Regulatory Networks in Breast Cancer Subtypes, Its Clinical Relevance and a Novel Association With Androgen Receptor and EMT.Semantic proximity Read ↗

p53 in breast cancer subtypes and new insights into response to chemotherapy.Semantic proximity Read ↗

Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations.Semantic proximity Read ↗

What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors?Semantic proximity Read ↗

Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation.Semantic proximity Read ↗

TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancerSemantic proximity Read ↗

Prognostic value of mutations in TP53 and RAS genes in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.